Hippocampal Glutamate, Resting Perfusion and the Effects of Cannabidiol in Psychosis Risk (2023)

First Author: Davies C

Attributed to: CANNABIDIOL AS A NOVEL THERAPEUTIC AGENT FOR PATIENTS AT ULTRA HIGH-RISK OF PSYCHOSIS: AN EXPERIMENTAL MEDICINE APPROACH funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2023.03.02.23286709

Publication URI: http://dx.doi.org/10.1101/2023.03.02.23286709

Type: Preprint